EAN paper

'Harmonized Acquisition of Connectome MRI and Clinical Data for Stroke, Parkinson's Disease and Glioma: Delphi-Derived Protocol Recommendations' has been published in a special issue of the European Journal of Neurology (EJoN)

A new paper from the EAN Environmental Influences in Neurology Task Force highlights the links between climate change, neurological health and brain health, and sets out priorities for action within neurology.

The annual societal cost of Parkinson's disease across Europe reached €22.8 billion in 2019 according to a new study within the EAN-led Cost of Illness in Neurology in Europe (COIN-Eu) initiative.

Dementia imposes huge cost across 30 high-income European countries, with families and unpaid informal carers carrying much of the burden, according to the COIN-Eu study published in the Journal of Alzheimer’s Disease.

A new COIN‑EU publication reveals that sleep disorders—affecting up to 30% of Europeans—carry a far greater health and economic burden than previously recognized, costing nearly €423 billion each year.

A new EAN guideline on the diagnostic approach to oligo/asymptomatic hyperCKemia has been published in the European Journal of Neurology

For the first time, guidelines for the management of urogenital symptoms reported by have been developed specifically for neurologists through a collaboration between the EAN, the International Neuro-Urology Society (INUS) and the European Federation of Autonomic Societies (EFAS).

A new EAN paper published in the European Journal of Neurology presents a roadmap toward reducing the burden imposed on patients, caregivers, and society by neurological diseases in Europe.

We are excited to announce the publication of our Sustainability Report 2024, which highlights the steps we have taken to integrate sustainable practices throughout our operations and supply chains.

The European Academy of Neurology has published a strategic neurological research agenda as a position paper in the European Journal of Neurology, to address current gaps and set priority areas for new clinically relevant research.